IOC Reinstates Genetic Testing for Female Athletes Ahead of 2028 Olympics
Los Angeles – In a move sparking immediate debate, the International Olympic Committee (IOC) announced Thursday it will require chromosome testing for all athletes competing in women’s events at the 2028 Los Angeles Olympics. The decision, reversing a policy enacted in 2021 that allowed individual sports federations to determine their own eligibility rules, effectively bans transgender athletes and a significant number of athletes with intersex variations from participating in women’s competitions.
The IOC stated that eligibility for women’s Olympic events will now be “reserved for individuals of biological female sex,” specifically those who do not carry the SRY gene. This gene, located on the Y chromosome, is typically responsible for the development of male characteristics. The policy, approved during a meeting of the IOC’s executive commission, will be implemented starting with the Los Angeles Games and is not retroactive, meaning results from previous Olympics, including the recent Paris Games, will not be affected.
This marks a return to a policy previously in place from 1968 to 1996, before being abandoned due to concerns about invasiveness and discrimination. The decision, the first major action taken by Kirsty Coventry since becoming IOC president last year, places the onus on international federations and national sporting bodies to organize and administer these chromosomal tests. The IOC specified that testing will be required “once in an athlete’s lifetime.”
The move effectively reverses the more inclusive guidelines established in 2021, which granted individual sports federations the autonomy to set their own policies regarding transgender and intersex athlete participation. This previous framework allowed for a more nuanced approach, taking into account specific sport requirements and individual circumstances. Now, a uniform biological standard is being applied across all women’s events.
Notably, the modern policy will not impact the gold medal won by Algerian boxer Imane Khelif at the Paris Olympics. Khelif has publicly stated she carries the SRY gene but has consistently been recognized as female by the IOC. This case highlights the complexities surrounding biological sex and gender identity in elite sports.
The reintroduction of genetic testing raises significant ethical and practical questions. Critics argue that focusing solely on the presence of the SRY gene is an oversimplification of biological sex, which is far more complex and can involve a range of genetic and hormonal factors. Concerns have also been raised about the potential for privacy violations and the psychological impact of mandatory genetic testing on athletes.
The IOC’s decision is likely to face legal challenges and further fuel the ongoing debate about inclusivity and fairness in sports. It remains to be seen how international federations will implement the new policy and what accommodations, if any, will be made for athletes with intersex variations. The coming months will be crucial as sporting bodies grapple with the practical implications of this controversial new rule.
The next major checkpoint will be the individual responses from international federations, expected within the next quarter, outlining their plans for implementing the IOC’s new testing protocols. Archysport will continue to provide updates as this story develops.
What are your thoughts on the IOC’s decision? Share your opinions in the comments below.
